These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15114750)

  • 21. Primary Treatment of Peyronie's Disease: A 55-yr-old Male with 45° Dorsal Penile Curvature and Good Erectile Function.
    Ramasamy R
    Eur Urol Focus; 2018 Apr; 4(3):301. PubMed ID: 30369422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ultrasound-guided ESWT in Peyronie's disease plaques].
    Mirone V; Palmieri A; Granata AM; Piscopo A; Verze P; Ranavolo R
    Arch Ital Urol Androl; 2000 Dec; 72(4):384-7. PubMed ID: 11221076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peyronie's disease. Conservative and surgical therapy].
    Hauck EW; Diemer T; Weidner W
    Urologe A; 2006 Feb; 45(2):W243-57. PubMed ID: 16416142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathophysiology and management of Peyronie's disease in adult patients: an update].
    Alenda O; Beley S; Ferhi K; Cour F; Chartier-Kastler E; Haertig A; Richard F; Rouprêt M
    Prog Urol; 2010 Feb; 20(2):91-100. PubMed ID: 20142049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary findings from a new animal model for Peyronie's disease involving extracorporeal shock waves.
    Andrade E; Cortez I; Claro J; Pompeu E; Leite K; Paranhos M; Borra P; Lucon AM; Srougi M
    BJU Int; 2009 Apr; 103(8):1104-6. PubMed ID: 19021616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.
    Erdogru T; Savas M; Yilmaz N; Faruk Usta M; Koksal T; Ates M; Baykara M
    Asian J Androl; 2002 Sep; 4(3):187-90. PubMed ID: 12364974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Extra-corporeal lithotripsy in the treatment of Peyronie's disease. Use of a standard lithotriptor (Multiline Siemens) on "young" (less then 6 months old) plaques].
    Lebret T; Hervé JM; Lugagne PM; Barré P; Orsini JL; Butreau M; Botto H
    Prog Urol; 2000 Feb; 10(1):65-70; discussion 70-1. PubMed ID: 10785921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of extracorporeal shockwave therapy for Peyronie's disease.
    Srirangam SJ; Manikandan R; Hussain J; Collins GN; O'Reilly PH
    J Endourol; 2006 Nov; 20(11):880-4. PubMed ID: 17144855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease.
    Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Kim H; Trost LW; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ
    Andrology; 2014 Mar; 2(2):244-51. PubMed ID: 24574095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie's disease.
    Dell'Atti L; Ronchi P
    World J Urol; 2023 Sep; 41(9):2563-2568. PubMed ID: 37490060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Extracorporeal shock wave therapy in Peyronie's disease: no convincing results].
    Hausmann R; Hauck E; Weidner W
    Aktuelle Urol; 2004 Sep; 35(5):356-7. PubMed ID: 15383994
    [No Abstract]   [Full Text] [Related]  

  • 33. A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease.
    Gao L; Qian S; Tang Z; Li J; Yuan J
    Int J Impot Res; 2016 Sep; 28(5):161-6. PubMed ID: 27250868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
    Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
    J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie's disease using two different electromagnetic lithotripters.
    Rassweiler JJ; Scheitlin W; Goezen AS; Radecke F
    World J Urol; 2024 Mar; 42(1):124. PubMed ID: 38453751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials.
    Hauck EW; Mueller UO; Bschleipfer T; Schmelz HU; Diemer T; Weidner W
    J Urol; 2004 Feb; 171(2 Pt 1):740-5. PubMed ID: 14713800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peyronie's disease: a review.
    Briganti A; Salonia A; Deho F; Zanni G; Rokkas K; Rigatti P; Montorsi F
    Curr Opin Urol; 2003 Sep; 13(5):417-22. PubMed ID: 12917519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extracorporeal shock wave therapy for Peyronie's disease].
    Ochoa A; Guillot-Tantay C; Faix A; Misrai V; Rouprêt M
    Prog Urol; 2020 Sep; 30(10):488-499. PubMed ID: 32370921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.
    Palmieri A; Imbimbo C; Longo N; Fusco F; Verze P; Mangiapia F; Creta M; Mirone V
    Eur Urol; 2009 Aug; 56(2):363-9. PubMed ID: 19473751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial comment on: A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.
    Martin Morales A
    Eur Urol; 2009 Aug; 56(2):369-70. PubMed ID: 19473749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.